Research & Development



人都來估價,七嘴八舌。瞎說一氣。要是給她時間去打听,那就全完蛋了。 他心里這樣翻騰不已,可是嘴巴卻十分巴結地說個不停︰ 于是我唉聲嘆氣表示遺憾。“真可惜,我真的非常樂意到府上去。可是今天 的事都弄擰了,我們晚上有個社交晚會,我不參加不行啊。”在线看片av免费观看 “好吧,明天一定來。”說著,汽車已經開走了。97自拍超频在线 “‘然而最可怕的是打官司,一打起來,你想講和也沒用,你就陷在沒 国产视频偷拍a在线观看

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo